Jam

  • Hanover Home Report: Homeowners in 2025 Have Numerous Opportunities to Enhance Safety

    The 2025 Hanover Home Report reveals growing homeowner awareness of risk prevention. While understanding water damage, structural safety, and fire prevention is high, adoption of protective measures like water sensors and fortified roofing lags. The report encourages homeowners to embrace technology, conduct regular inspections, and practice proactive maintenance to reduce potential losses.

    2025年6月2日
  • NUTEX Health Announces Proxy Materials Availability for 2025 Annual Meeting Online

    Nutex Health Inc. (NUTX) announced its 2025 annual shareholder meeting details and availability of proxy materials. The virtual meeting is scheduled for July 14, 2025, and accessible online. Shareholders can access documents via several methods, including www.ProxyVote.com. Nutex operates micro-hospitals and physician networks, aiming to streamline healthcare. The announcement includes forward-looking statements and encourages shareholder participation.

    2025年6月2日
  • Clean Air Metals Files Audited FY2025 Financial Results

    Clean Air Metals Inc. has released its audited financial statements for the fiscal year ending January 31, 2025. Key figures include total assets of $37.9 million and a net loss of $3.1 million. The company will hold its Annual General Meeting on July 29, 2025. Clean Air Metals is advancing its Thunder Bay North project and expects to release a new Preliminary Economic Assessment this fall.

    2025年6月2日
  • CW Bancorp Quarterly Cash Dividend

    CW BANCORP announced a quarterly cash dividend of $0.23 per share, payable July 1, 2025, to shareholders of record June 16, 2025. CommerceWest Bank, its subsidiary, focuses on California’s small and medium-sized businesses. The bank provides commercial banking services, including digital banking, loans for various purposes, and treasury management. The dividend reflects a commitment to shareholder returns and supporting California businesses.

    2025年6月2日
  • Royce Micro-Cap Trust, Inc. Announces Q2 Common Stock Distribution of $0.18 Per Share (NYSE: RMT)

    Royce Micro-Cap Trust (RMT) announced a $0.18 per share quarterly distribution, payable June 25, 2025, with shareholders able to choose cash or additional shares. The distribution rate is currently 7% annually, subject to change. As of May 31, 2025, the distribution source is primarily long-term gains. The fund’s 5-year average annual total return is 12.71%.

    2025年6月2日
  • Cronos Group Inc. to Present at TD Cowen’s 9th Annual Future of the Consumer Conference

    Cronos Group Inc. announced CEO Mike Gorenstein will present at the TD Cowen Future of the Consumer Conference on June 4, 2025. The company, focused on cannabinoid innovation with brands like Spinach and Lord Jones, aims to shape the consumer experience through research and development. The live webcast will be available on Cronos’ investor relations website. This release includes forward-looking statements.

    2025年6月2日
  • Cogent’s Notes Offering Launches

    Cogent Communications (CCOI) will issue $600 million in senior secured notes due 2032, offered to qualified institutional buyers, via its subsidiaries. Proceeds will refinance its outstanding $500 million notes due 2026 and provide operational flexibility, including potential shareholder dividends. This offering, which is not guaranteed, will not be registered and has specific trading limitations. Cogent, a major bandwidth provider, operates globally.

    2025年6月2日
  • Aon Names Andy Marcell CEO of Global Solutions

    Aon plc is restructuring its leadership, with Andy Marcell becoming CEO of Global Solutions, overseeing integrated client services in risk and human capital. This move supports Aon’s “3×3 Plan” and leverages Marcell’s success integrating Risk Capital. Lambros Lambrou becomes Global Chief Strategy Officer. These changes align with the insights from Aon’s Client Trends 2025 report and aim to address evolving client needs.

    2025年6月2日
  • Five-Year Analysis of Amtagvi® (lifileucel) in Advanced Melanoma Patients Published in The Journal of Clinical Oncology

    Iovance Biotherapeutics announced five-year follow-up data for Amtagvi (lifileucel) in advanced melanoma. Results from the Phase 2 trial show deep, durable responses with one-third of patients maintaining ongoing responses after five years. Median overall survival was 13.9 months, with a five-year survival rate of 19.7%. The therapy, already FDA-approved, provides a new treatment option for patients with advanced melanoma who progressed after prior therapies.

    2025年6月2日
  • Campbell’s Q3 Fiscal 2025 Results Announced

    Campbell’s Q3 net sales rose 4% to $2.5 billion, with organic growth of 1%. Adjusted EBIT increased 2% to $362 million, while adjusted EPS decreased 3% to $0.73. The company maintained its fiscal year 2025 guidance, anticipating adjusted EPS at the lower end of the range. They also returned $403 million to shareholders.

    2025年6月2日